Cite
HARVARD Citation
Fernandez Parra, E. et al. (n.d.). 2543 Weekly cabazitaxel in "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial. European journal of cancer. pp. S490-. [Online].